Publication | Closed Access

Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients

Tumor ImmunologyT-cells CorrelateCancer ImmunosurveillanceMelanomaImmunologyImmune Checkpoint InhibitorAutoimmunityCellular Immune ResponseImmune Cell TherapyImmunotherapyMedicineCell BiologyTumor Microenvironment